Skip to main content

How do you take Ubrelvy tablets?

Medically reviewed by Melisa Puckey, BPharm. Last updated on June 19, 2023.

Official answer

by Drugs.com

Ubrelvy is a tablet that is taken orally when you have a migraine, a second dose may be taken after 2 hours in some cases.

Ubrelvy (ubrogepant) is a tablet that is used to treat migraines in adults.

You take Ubrelvy when you have the migraine, it is NOT used to prevent migraines.

How do you take Ubrelvy?

  • Ubrelvy is available as a 50 mg tablet and a 100mg tablet. Your prescriber will determine which dose is correct for you.
  • The tablet is taken orally (swallowed with a glass of water) when you have a migraine.
  • Ulbrelvy can be taken with or without food. If you need to, you can take a second tablet 2 hours after the first dose, however you should NOT take a second dose if you have consumed grapefruit or grapefruit juice, or take any of these medications: verapamil, cyclosporine ciprofloxacin, fluconazole or fluvoxamine.
  • The safety of using Ubrelvy to treat more than 8 migraines over 30 days is not known.

What does Ubrelvy do?

Ubrelvy helps reduce the pain from migraines, and in some cases completely will completely stop the pain.

Ubrelvy also helps bothersome migraine symptoms such as light sensitivity, sound sensitivity, or nausea.

References

Ubrelvy medicine information: https://www.drugs.com/dosage/ubrelvy.html

Read next

Ubrelvy, Qulipta and Nurtec ODT are all medicines used by adults for migraines. They are all from the same group of medicines often called gepants but their full name is calcitonin gene-related peptide (CGRP) receptor antagonist. Continue reading

Ubrelvy and Imitrex are both oral tablets used to treat migraine, but there are differences in the way they work. Ubrelvy prevents a protein called CGRP thought to play a role in migraine attacks from binding to its receptor and Imitrex is thought to bind to serotonin 5‑HT1B/1D receptors, and inhibit pro-inflammatory substances Although no head-to-head comparison trials compare Ubrelvy to Imitrex, indirect evidence suggests that overall, Ubrelvy is no more effective, and may be inferior to Imitrex at relieving migraine in adults who are able to tolerate triptans. For those adults with moderate-to-severe migraine attacks that cannot tolerate triptans or who have found them ineffective, Ubrelvy is beneficial for treating migraines compared to no treatment. Ubrelvy is associated with fewer side effects than Imitrex, but is more expensive, costing almost twice as much. Continue reading

Some patients may not be able to use NSAIDs or triptans to treat acute migraine headaches due to side effects or health conditions. In these circumstances, newer agents like Ubrelvy (ubrogepant), a calcitonin gene-related peptide (CGRP) antagonist, may be an appropriate option. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer